IRIS
CAPORALI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.756
AS - Asia 9.374
EU - Europa 6.792
SA - Sud America 1.266
Continente sconosciuto - Info sul continente non disponibili 520
AF - Africa 290
OC - Oceania 19
Totale 32.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.404
CN - Cina 4.665
SG - Singapore 1.986
IE - Irlanda 1.581
HK - Hong Kong 982
BR - Brasile 979
UA - Ucraina 915
VN - Vietnam 843
FI - Finlandia 840
DE - Germania 752
RU - Federazione Russa 721
IT - Italia 458
SE - Svezia 453
FR - Francia 429
GB - Regno Unito 320
CA - Canada 189
IN - India 182
ZA - Sudafrica 152
BD - Bangladesh 115
AR - Argentina 99
IQ - Iraq 83
TR - Turchia 74
JP - Giappone 72
MX - Messico 54
ID - Indonesia 49
PL - Polonia 47
SA - Arabia Saudita 46
CO - Colombia 45
AT - Austria 44
PK - Pakistan 42
EC - Ecuador 39
NL - Olanda 36
ES - Italia 35
VE - Venezuela 33
MY - Malesia 31
CZ - Repubblica Ceca 29
PH - Filippine 29
BE - Belgio 28
MA - Marocco 27
CL - Cile 23
TN - Tunisia 20
JM - Giamaica 19
EG - Egitto 17
UZ - Uzbekistan 17
IL - Israele 16
AU - Australia 14
CR - Costa Rica 14
IR - Iran 14
LT - Lituania 14
UY - Uruguay 14
DO - Repubblica Dominicana 13
JO - Giordania 13
NP - Nepal 13
OM - Oman 13
KE - Kenya 12
PY - Paraguay 12
SN - Senegal 12
AE - Emirati Arabi Uniti 11
ET - Etiopia 11
TT - Trinidad e Tobago 11
PE - Perù 10
AL - Albania 9
BO - Bolivia 9
HU - Ungheria 9
SY - Repubblica araba siriana 9
AZ - Azerbaigian 8
HN - Honduras 8
KG - Kirghizistan 8
RO - Romania 8
DK - Danimarca 7
DZ - Algeria 7
EE - Estonia 7
KR - Corea 7
KZ - Kazakistan 7
MU - Mauritius 7
NI - Nicaragua 7
PA - Panama 7
GR - Grecia 6
GT - Guatemala 6
LV - Lettonia 6
LB - Libano 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
EU - Europa 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AO - Angola 3
BB - Barbados 3
CU - Cuba 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
LK - Sri Lanka 3
MM - Myanmar 3
PR - Porto Rico 3
Totale 31.439
Salva come PNG Salva come JPEG
Città #
Dublin 1.577
San Jose 1.476
Chandler 1.470
Jacksonville 1.282
Ashburn 1.106
Nanjing 1.066
Hong Kong 965
Singapore 956
Council Bluffs 769
Dallas 741
Beijing 646
Boardman 490
Nanchang 426
Princeton 371
Lawrence 328
Wilmington 322
Changsha 311
Los Angeles 309
Shenyang 308
Lauterbourg 306
Hebei 304
Ho Chi Minh City 300
Helsinki 273
Medford 245
Jiaxing 231
Hanoi 197
Hangzhou 177
Tianjin 175
Ann Arbor 161
New York 159
Munich 150
Johannesburg 129
Moscow 127
Redondo Beach 124
Shanghai 118
Buffalo 116
Santa Clara 116
Milan 111
São Paulo 95
Woodbridge 81
Pavia 68
Norwalk 65
Orem 62
Tokyo 59
Toronto 59
Brooklyn 57
Da Nang 54
Seattle 53
Turku 50
Chicago 49
Verona 49
Houston 44
Montreal 41
Atlanta 39
Fairfield 38
Warsaw 38
Haiphong 36
San Francisco 36
Chennai 34
Falkenstein 34
London 33
Phoenix 33
Denver 30
Washington 30
Boston 29
Brasília 28
Brussels 28
The Dalles 28
Frankfurt am Main 27
Guangzhou 27
Vienna 27
Jinan 25
Rio de Janeiro 25
Ankara 24
Baghdad 24
Stockholm 24
Zhengzhou 24
Columbus 23
Porto Alegre 23
Kunming 20
Manchester 20
Poplar 20
Rome 20
Amsterdam 19
Belo Horizonte 19
Brno 19
Des Moines 19
Ningbo 19
Nuremberg 19
Jeddah 18
Secaucus 18
Dhaka 17
Charlotte 16
Orange 16
Pune 16
Queens 16
Riyadh 16
Biên Hòa 15
Auburn Hills 14
Campinas 14
Totale 20.461
Salva come PNG Salva come JPEG
Nome #
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 174
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 161
B cells in rheumatoid arthritis. 161
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 159
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 156
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 151
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 150
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 149
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 147
DMARDS and infections in rheumatoid arthritis 146
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 146
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 146
A case of adult onset Still's disease treated with infliximab - Reply 146
Disease-related malnutrition in systemic sclerosis: Evidences and implications 144
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 143
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 141
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 141
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 139
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 137
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 137
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 134
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 134
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 133
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 132
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 131
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 131
Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients 130
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 130
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 129
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 129
Shrinking lung syndrome in sistemic sclerosis 129
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 128
B cells in rheumatoid arthritis. 128
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 127
Diffuse skin reaction after changing the etanercept formulation 127
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. 125
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 125
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 125
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 123
Analysis of Human Myeloma Cell-population Kinetics 123
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 122
Uterine artery Doppler velocimetry and obstetric outcomes in connective tissue diseases diagnosed during the first trimester of pregnancy. 122
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 122
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 122
Analysis of pharmacologic and nonpharmacologic prescription patterns of general practitioners and specialists in the AMICA study. 122
Association between anti-dsDNA titre increase and thymoma relapse 121
Spondiliti e spondilodisciti batteriche. 121
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 121
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 120
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 120
Interessamento cutaneo nella dermatomiosite 119
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 118
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 118
Influenza may influence rheumatoid arthritis 117
A Seasonal Pattern In the Onset of Polymyalgia Rheumatica 117
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 117
Fetal programming and systemic sclerosis 116
Biosimilars: Lights and shadows in rheumatology 115
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 115
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 114
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 114
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 114
Prednisone plus Methotrexate for polymyalgia rheumatica. A randomized, double blind, placebo-controlled trial. 114
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 114
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes 114
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 113
Efficacy and safety of anti-TNF agents in the Lombardy Rheumatoid Arthritis Network (LORHEN) 113
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 112
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 112
Connective tissue diseases and autoimmune thyroid disorders in the first trimester of pregnancy 112
The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome 112
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study 112
Osteoarthritis: An overview of the disease and its treatment strategies 111
[New classification criteria for rheumatoid arthritis]. 111
Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry 111
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 111
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 110
Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes 110
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 110
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 110
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis. 109
The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity. 109
Safety of Mud-Bath Applications in Moderately Active Rheumatoid Arthritis 108
Biomarkers and prognostic stratification in psoriatic arthritis. 108
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more 108
Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy 108
Early, incomplete, or preclinical autoimmune systemic rheumatic diseases and pregnancy outcome 108
Autoimmunity in thrombotic thrombocytopenic purpura 107
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine 107
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 107
Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease 107
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 106
Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? 106
Anticardiolipin Antibodies In Pediatric Systemic Lupus-erythematosus 105
Hematological Abnormalities Associated With Anticardiolipin Antibodies 105
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis 105
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today 105
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 105
Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical 104
Diffuse skin reaction after changing the etanercept formulation. Clin Exp Rheumatol. 104
Totale 12.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 144.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.280 0 0 0 14 18 38 44 99 66 20 207 774
2022/20234.426 532 295 37 266 465 466 2 260 1.875 33 116 79
2023/20241.517 169 339 63 115 156 381 16 98 10 49 47 74
2024/20254.179 100 371 96 114 50 175 159 312 1.032 131 458 1.181
2025/202610.006 784 706 1.184 1.017 1.096 404 2.051 419 855 707 414 369
2026/20272.306 177 581 727 821 0 0 0 0 0 0 0 0
Totale 32.017